Celator Pharmaceuticals' Grant

Celator Pharmaceuticals raised a round of funding on August 24, 2009. Investors include Qualifying Therapeutic Discovery Project.

Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identif…

Articles about Celator Pharmaceuticals' Grant: